Edwards Lifesciences (EW) Other Operating Expenses (2017 - 2026)

Edwards Lifesciences has reported Other Operating Expenses for 5 years, with the latest figure at $11.0 million in Q2 2026.

• On a quarterly basis, Other Operating Expenses fell 48.36% year-over-year to $11.0 million in Q2 2026; TTM through Jun 2026 was $52.0 million, a 27.76% increase from a year earlier, with the FY2025 full-year figure at $67.2 million, up 22300.0% from the prior year.
• Other Operating Expenses was $11.0 million for Q2 2026 at Edwards Lifesciences, down from $14.2 million in the prior quarter.
• The five-year high for Other Operating Expenses was $22.7 million in Q4 2024, with the low at -$22.4 million in Q3 2024.
• Average Other Operating Expenses over 3 years is $11.6 million, with a median of $14.2 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses soared 155.8% in 2025, then plunged 48.36% in 2026.
• Over 3 years, Other Operating Expenses stood at $22.7 million in 2024, then tumbled by 37.0% to $14.3 million in 2025, then slipped by 23.08% to $11.0 million in 2026.
• The last three Other Operating Expenses figures came in at $11.0 million (Q2 2026), $14.2 million (Q1 2026), and $14.3 million (Q4 2025), per Business Quant data.